Highly selective and tunable protein hydrolysis by a polyoxometalate complex in surfactant solutions: A step toward the development of artificial metalloproteases for membrane proteins by Sap, Annelies et al.
Highly Selective and Tunable Protein Hydrolysis by a
Polyoxometalate Complex in Surfactant Solutions: A Step toward the
Development of Artiﬁcial Metalloproteases for Membrane Proteins
Annelies Sap,† Laurens Vandebroek,† Vincent Goovaerts,† Erik Martens,‡ Paul Proost,‡
and Tatjana N. Parac-Vogt*,†
†Department of Chemistry, KU Leuven, Celestijnenlaan 200F, Box 2404, 3001 Leuven, Belgium
‡Department of Microbiology and Immunology, KU Leuven, Herestraat 49, Box 1042, 3000 Leuven, Belgium
*S Supporting Information
ABSTRACT: This study represents the ﬁrst example of
protein hydrolysis at pH = 7.4 and 60 °C by a metal-
substituted polyoxometalate (POM) in the presence of a
zwitterionic surfactant. Edman degradation results show that in
the presence of 0.5% w/v 3-[(3-cholamidopropyl)-
dimethylammonio]-1-propanesulfonate (CHAPS) detergent,
a Zr(IV)-substituted Wells−Dawson-type POM, K15H[Zr(α2-
P2W17O61)2]·25H2O (Zr1-WD2), selectively hydrolyzes
human serum albumin exclusively at peptide bonds involving
Asp or Glu residues, which contain carboxyl groups in their
side chains. The selectivity and extent of protein cleavage are
tuned by the CHAPS surfactant by an unfolding mechanism
that provides POM access to the hydrolyzed peptide bonds.
■ INTRODUCTION
On the basis of complete sequencing of several genomes, 30%
of all proteins are estimated to be hydrophobic membrane
proteins.1,2 The study of the structure and function of this large
class of proteins is essential as they are among the prime drug
targets. In fact, 60% of the current drug targets are located on
the cell surface.3 The large size, structural complexity, and
intrinsic hydrophobicity of these biomolecules often complicate
their structural investigations by the existing experimental
methods. Therefore, controlled fragmentation of membrane
proteins into smaller fragments remains a key approach to
facilitate their structural analysis.4 However, this requires the
hydrolysis of the peptide bond, which has an estimated half-life
of between 350 and 600 years under physiological con-
ditions.5−7 In addition, as a result of their hydrophobic nature,
membrane proteins are insoluble in aqueous solutions, and
denaturation is often encountered. Therefore, the addition of
surfactants is often essential to mimic a hydrophobic environ-
ment and stimulate solubilization of membrane proteins.
Generally, the concentration of the surfactant should be
maintained above the critical micelle concentration (CMC),8
and therefore, relatively high surfactant concentrations (usually
in the range of 0.5−1.0% w/v) are required.9
Proteolytic enzymes are often used to hydrolyze peptide
bonds in proteins for many purposes in biochemistry,
biotechnology, and proteomics. However, they are very
sensitive to the experimental conditions and often undergo
denaturation in the presence of surfactants, which results in the
loss of catalytic activity. Therefore, they are not suitable for the
hydrolysis of hydrophobic and membrane proteins. Con-
sequently, there is an urgent need for new synthetic proteases
that are compatible with surfactants and can eventually be used
to hydrolyze membrane proteins in an eﬃcient and selective
manner under mild reaction conditions.
Several metal complexes have been shown to induce
hydrolysis of peptide bonds in proteins;10−16 however, their
catalytic ability under the conditions pertinent to membrane
proteins has been largely unexplored. PdII and PtII complexes
have been studied for the selective hydrolysis of proteins in
solutions containing surfactants;9,16 however, very low pH
conditions (2.5−2.9) were required to observe the reactivity,
which is disadvantageous as this often leads to pronounced
background cleavage and also results in denaturation of the
protein under study. More recently, a Ni(II)-containing
complex has been shown to cleave a terminal aﬃnity tag
from a recombinant fusion protein, thus providing an
interesting alternative for currently used techniques.17
Polyoxometalates (POMs) are a class of inorganic metal−
oxygen clusters with a range of tunable properties.18−20 POMs
are commercially used as catalysts in a wide range of chemical
reactions.21−24 Moreover, the biological activity of POMs has
been reported with respect to their antiviral, antibacterial, and
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anticancer properties.25−28 We have recently demonstrated that
POMs exhibit reactivity toward a range of biologically relevant
molecules and their model systems.29−34 Recently, the ability of
metal-substituted POMs to act as a novel class of artiﬁcial
peptidases has been introduced by our group. Zr(IV)-
substituted POMs have been proven to selectively cleave
proteins, ranging from a small, ﬂexible polypeptide system, such
as oxidized insulin chain B,35 to larger protein systems with a
deﬁned tertiary structure and surface charge, such as hen egg
white lysozyme (HEWL),36 human serum albumin (HSA),37,38
myoglobin,39 and cytochrome c.40 The hydrolytic experiments
were performed in aqueous solutions under physiological pH
conditions; however, to develop Zr(IV)-substituted POMs as
artiﬁcial proteases for hydrophobic proteins, their activity as
catalysts in the presence of surfactants needs to be established.
We recently demonstrated that in the presence of anionic,
Figure 1. (a) Equilibria between the 1:2, 1:1, and 2:2 species of the Zr(IV)-substituted Wells−Dawson POM. WO6 octahedrons are represented in
blue, PO4 tetrahedrons in red, and Zr(IV) in green. (b) Chemical structure of the zwitterionic surfactant, CHAPS.
Figure 2. Silver-stained sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gels of HSA hydrolysis by Zr1-WD2 POM in
phosphate buﬀer (10 mM, pH 7.4) at 60 °C in the absence and presence of surfactants: Inﬂuence of increasing % w/v CHAPS after 2 days of
incubation. From left to right: protein ladder; 0.0, 0.2, 0.5% CHAPS; protein ladder; 1.0, 2.0% CHAPS.
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neutral, and zwitterionic surfactants, the Zr(IV)-substituted
Wells−Dawson POM, K15H[Zr(α2-P2W17O61)2] (1), preserves
its catalytic activity toward hydrolysis of the peptide bond in
dipeptides.41 Diﬀusion Ordered NMR Spectroscopy (DOSY)
has shown that anionic and neutral surfactants do not exhibit
any interaction with 1, whereas a tertiary system is formed
between the dipeptide, POM, and the surfactant in the
presence of zwitterionic surfactants such as 3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate
(CHAPS). The interaction between 1 and CHAPS occurs
through the positively charged ammonium group, whereas, at
the same time, the negative charge of the sulfonate group
attenuates this electrostatic interaction. Thereby, precipitation
that typically occurs in the presence of positively charged
surfactants is prevented.41,42 However, the applicability of
Zr(IV)-substituted POMs toward protein hydrolysis in
surfactant solutions is challenging because interactions between
the POM and the surfactant may shield POM binding to the
protein, which is largely electrostatic in nature. Moreover, the
partial unfolding of the protein caused by surfactants may aﬀect
the selectivity of protein hydrolysis by altering POM/protein
interactions, which are proposed to occur according to the lock
and key principle.25,43 Therefore, in this study, we explore the
compatibility of 1 to act as a metalloprotease for the hydrolysis
of HSA in the presence of the zwitterionic surfactant, CHAPS
(see Figure 1), which is widely used for solubilizing membrane
proteins.44,45 HSA consists of 585 amino acids and serves as an
excellent model for studying the hydrolytic activity of Zr-POMs
in surfactant solutions. The protein has been structurally well
characterized, and its hydrolysis by the Zr-POMs has been
studied in detail. This oﬀers the possibility to elucidate the role
of the detergents in the activity and selectivity of the catalyst.
■ RESULTS AND DISCUSSION
In the hydrolysis experiments, HSA (0.02 mM) was incubated
with 1 in phosphate buﬀer (10 mM, pH 7.4) at 60 °C in the
presence of diﬀerent concentrations of CHAPS (0.0−2.0% w/
v). To monitor the progress of the reaction, aliquots of the
homogeneous reaction mixture were ﬁrst taken at diﬀerent time
intervals. Then, the polypeptide fragments that were formed as
a result of protein hydrolysis were separated by SDS-PAGE.
The presence of multiple bands on SDS-PAGE (see Figure 2)
clearly indicate that 1 is able to hydrolyze HSA in the presence
of up to 2.0% w/v CHAPS, which is well above its CMC (0.5%
w/v) and above the range of surfactant concentrations that are
typically used for solubilization of membrane proteins (0.5−
Figure 3. 3D structure and surface charge distribution. Negatively charged surface areas are shown in red, and positively charged surface areas are
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1.0% w/v).9 Interestingly, an increase in CHAPS concentration
led to a gradual decrease in the number and intensity of the
bands in SDS-PAGE. Longer incubation times resulted in more
intense bands, which is consistent with the increasing yields of
protein fragmentation (see Figure S1). Our previous studies
have shown that no hydrolysis of HSA was observed in the
absence of the Zr-POMs.37,38 In the presence of the lacunary
Wells−Dawson K10[α2-P2W17O61]·20H2O POM, no hydrolysis
was observed either, indicating that the presence of Zr(IV) is
essential for the hydrolytic activity. Moreover, when the ZrCl4
salt was used, limited hydrolysis yields and the formation of
insoluble Zr(IV) gels were observed, emphasizing the need of
the POM as a Zr(IV)-stabilizing and protein-recognizing ligand.
Edman degradation of polypeptide fragments observed in
SDS-PAGE unambiguously conﬁrmed that, in the presence of
0.5% CHAPS, HSA was hydrolyzed by 1 at seven distinct sites:
Cys62−Asp63, Gly71−Asp72, Asp107−Asp108, Lys313−
Asp314, His367−Glu368, Ser470−Asp471, and Ala511−
Asp512 visible on the gel (see Figures S2 and S3 and Table
S1). Remarkably, all of the hydrolyzed peptide bonds in HSA
were upstream from either the Asp or the Glu amino acid, both
of which contain a carboxyl group in their side chains. This is in
full accordance with our previous ﬁndings, which showed that,
in the absence of surfactants, proteins were mainly hydrolyzed
next to Asp or Glu residues that were located in the positive
patches of proteins. The high selectivity of Zr(IV) toward
hydrolyzing peptide bonds that involve Asp and Glu residues
can be rationalized by two explanations: (i) the anchoring of
the carboxyl group side chain to Zr(IV), or (ii) by the ability of
the deprotonated carboxyl group to accept a proton from the
coordinated water molecule, making it a more eﬀective
nucleophile.46 Interestingly, CHAPS plays a signiﬁcant role in
tuning the reactivity and selectivity of 1 toward HSA hydrolysis.
In the absence of CHAPS, the cleavage was observed at four
peptide bonds (Arg114−Leu115, Ala257−Asp258, Lys313−
Asp314, Cys302−Glu303), whereas seven cleavage sites were
observed in the presence of CHAPS. Interestingly, all cleaved
peptide bonds are located in the vicinity of a positively charged
surface patch that can electrostatically interact with the
negatively charged POM surface (Figure 3). With the exception
of the hydrolysis site, Lys313−Asp314, which is observed both
in the absence of CHAPS and in the presence of 0.5% CHAPS,
the surfactant is clearly responsible for altering the selectivity
and generating an increase in the number of cleavage sites.
Surfactants are known to break noncovalent interactions in
proteins,47 and it is likely that this results in the opening of the
three-dimensional (3D) structure of HSA, making the potential
X−Asp cleavage sites more accessible for hydrolysis.
Circular dichroism (CD) measurements shown in Figure 4
show a clear indication that CHAPS interacts with HSA in such
a way that the α-helical content of HSA gradually lowers from
1.0% CHAPS onward, indicating a partial unfolding of the
protein. In addition, Figure S5 shows that, under a constant
CHAPS concentration and increasing concentrations of 1, a
slight decrease in α-helix takes place, indicating that interactions
between 1 and HSA take place in the surfactant solution.
It has been known that 1 undergoes equilibria in solution and
that diﬀerent species can be present depending on the
experimental conditions, such as concentration, pH, temper-
ature, or incubation time. The monomeric 1:1 species, which is
presumed to be the catalytically active species, is a very elusive
species due to the fast equilibria between the diﬀerent POMs
(see Figure 1). However, we were recently able to isolate a
noncovalent complex formed between the structurally analo-
gous Zr-Keggin POM and HEWL. The single crystal X-ray
structure of the complex showed that the monomeric Zr-
Keggin POM was exclusively present in the co-crystal with the
protein, giving the ﬁrst full structural evidence for the existence
of the catalytically active form.48 Furthermore, the structural
model showed that the POM initially binds to positively
charged patches on the surface of the protein. The interaction
types vary from water-mediated hydrogen bonds to direct
electrostatic interactions, but overall, the interaction seems to
be directed by the electrostatic attraction between the
negatively charged POM ligand and the positively charged
amino acid side chains.48
To study the inﬂuence of increasing CHAPS concentrations
on solution speciation of the POMs, 31P NMR spectroscopy
was further applied (see Figure S6). In the absence of CHAPS,
1 is present as the dimeric species (Zr1-WD2), whereas upon
an increase in % CHAPS, a gradual conversion takes place, in
which 1 partially transforms into α2-P2W17. As α2-P2W17 is
hydrolytically inactive, this conversion could explain the gradual
decrease in reactivity observed upon an increase in % CHAPS.
In addition, 31P NMR measurements were taken to understand
the interaction behavior between 1 and HSA in the presence of
0.5% CHAPS (see Figure S7). The dimeric species of 1 (Zr1-
WD2) is predominantly present in solution in the absence of
HSA. However, upon increasing concentrations of HSA, a
gradual disappearance of the signal corresponding to 1 is
observed. This clearly demonstrates that in the presence of
0.5% CHAPS, 1 interacts with HSA to form a POM/HSA
complex with a longer correlation time and consequently a
faster T2 relaxation.49
Tryptophan (Trp) ﬂuorescence quenching is a powerful tool
to study binding of diﬀerent molecules to a protein, and it was
further used to study the interaction between 1 and HSA in the
presence of CHAPS. HSA contains only one Trp residue at
position Trp-214, and the overall protein emission is
dominated by this residue, which absorbs at the longest
wavelength and displays the largest extinction coeﬃcient.
Energy absorbed by phenylalanine (Phe) and Tyr residues is
often eﬃciently transferred to the Trp residues in the same
protein.50 In a ﬁrst step, the eﬀect of the CHAPS on the Trp
Figure 4. CD spectra of HSA (5 μM) in phosphate buﬀer (10 mM,
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ﬂuorescence of HSA was investigated (see Figure S8). In these
steady-state ﬂuorescence experiments, the concentration of
HSA was kept constant, whereas the concentration of CHAPS
was increased from 0 to 5% w/v. Interestingly, it was found that
the emission wavelength at the maximum intensity decreased
from 342 to 328 nm as a result of the added CHAPS. The more
hydrophobic environment, which is created by the addition of
CHAPS, results in the shift in the emission maximum to lower
wavelengths.50
Subsequently, the eﬀect of the presence of 0.5% w/v CHAPS
on the quenching of the Trp ﬂuorescence of HSA by 1 was
examined (see Figure 5). The concentrations of HSA and
CHAPS were kept constant, whereas the concentration of 1
was increased stepwise.51 Eﬀective quenching of Trp
ﬂuorescence by 1 was observed in the presence of CHAPS,
indicating that the presence of the surfactant does not hinder
POM/protein interactions. Analysis of the data by the Tachiya
model (see Experimental Section and Figure S10) revealed that
quenching of Trp ﬂuorescence was a result of the binding of
multiple Zr1-WD2 molecules to HSA.52 Although the value of
the quenching constant (Kq) of Trp by 1 in the presence of the
surfactant is slightly lower (3.0 × 105 M−1) than the Kq in the
absence of the surfactant (5.1 × 105 M−1), the model revealed
that more POM was bound per HSA unit when the surfactant
was present (Table S2). This is in accordance with the more
“open” 3D structure of the protein caused by the surfactant,
making the interaction sites more accessible for POM binding.
■ CONCLUSIONS
In conclusion, in this study, we have demonstrated that a metal-
substituted POM, K15H[Zr(α2-P2W17O61)2] (1), selectively
hydrolyzes a relatively large protein, HSA, in the presence of a
zwitterionic surfactant, CHAPS, under physiological pH
conditions. The POM catalyst preserves its hydrolytic activity
in the presence of surfactant concentrations well above those
that are typically used for solubilizing hydrophobic proteins.
Most importantly, in the presence of the surfactant, 1 acts as a
site-selective agent, hydrolyzing HSA exclusively at peptide
bonds containing amino acid residues that contain carboxyl
groups in their side chain. The hydrolyzed Asp and Glu peptide
bonds are either located in the positive patches of the protein
or contain positively charged amino acids such as Lys and His,
which aid electrostatic interaction with the negatively charged
POM surface. Interestingly, this study revealed that by partially
unfolding the 3D structure of proteins, surfactants can be used
as a means to tune the selectivity of hydrolysis by making the
potential cleavage sites more accessible to the POM catalyst.
We are currently investigating the hydrolysis of water-insoluble
proteins in surfactant solutions. These ﬁndings may be an
important step forward in developing Zr-substituted POMs as a
potential class of metalloproteases for the hydrolysis of
hydrophobic and membrane proteins.
■ EXPERIMENTAL SECTION
Chemicals . α -/β -K6P2W18O62 ·14/19H2O,




54 were prepared according to published procedures.
HSA was purchased from Sigma−Aldrich in the highest
available purity (≥99%) and was used without further
puriﬁcation.
Hydrolysis Study. Solutions containing HSA (0.02 mM)
and K15H[Zr-(α2-P2W17O61)2]·25H2O (1 mM) with diﬀerent
% w/v of CHAPS (0−10% w/v) were prepared in phosphate
buﬀer (10 mM, pH 7.4). Samples were incubated at 60 °C, and
aliquots were taken at diﬀerent time increments and analyzed
by SDS-PAGE.
Electrophoresis. SDS-PAGE was performed on a 16% (w/
v) polyacrylamide resolving gel (Tris−HCl buﬀer, 1.5 M, pH
8.8) and a 4% (w/v) polyacrylamide stacking gel (Tris−HCl,
0.5 M, pH 6.8). Each sample (15 μL) was mixed with the
sample buﬀer (5 μL) and heated to 95 °C for 5 min. A total of
10 μL of the resulting solution was loaded onto the gel. A
PageRuler prestained protein ladder (10−170 kDa) was used as
a molecular mass standard. An OmniPAGE electrophoretic cell
was used with an EV243 power supply (both produced by
Consort). Two SDS-PAGE gels were run at the same time in a
Tris−Glycine-SDS running buﬀer with the maximum voltage
set to 200 V, a constant current set to 70 mA, and the
maximum power set to 50 W. The total running time was
approximately 1.5 h. SDS-PAGE gels were visualized with silver
staining, and an image of each gel was taken using a GelDoc EZ
Imager (BioRad).
Edman Degradation. SDS-PAGE gels were blotted onto a
PVDF membrane (using a BioRad Trans-Blot Turbo RTA
Transfer Kit) and stained with Coomassie blue. Coomassie-
stained protein bands were cut from the membrane, destained
in methanol, and washed with ultrapure water to remove any
remaining salts before Edman degradation on a capillary
Procise 491cLC protein sequencer (Applied Biosystems).55
31P NMR Spectroscopy. To study the stability of the Zr-
POM with increasing % of the surfactant, solutions containing
K15H[Zr-(α2-P2W17O61)2]·25H2O (1 mM) and increasing %
w/v of CHAPS (0−2%) in phosphate buﬀer (10 mM, pH 7.4,
10% D2O) were prepared. To study the eﬀect of increasing
concentrations of HSA on the stability of Zr-POM in the
presence of a speciﬁc w/v % of the surfactant, solutions
containing K15H[Zr-(α2-P2W17O61)2]·25H2O (2 mM) and
HSA (0, 0.2, 0.4, or 0.5 mM) in a certain w/v % of the
surfactant (0.5% CHAPS) in phosphate buﬀer (10 mM, pH
7.4) were also prepared. 31P NMR spectra of the diﬀerent
Figure 5. Emission ﬂuorescence spectra of HSA in the presence of
diﬀerent concentrations of Zr1-WD2 ([HSA] = 10−5 M, [CHAPS] =
0.5 wt %, pH = 7.4). From top to bottom, the concentration of Zr1-
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samples were recorded after mixing and after incubation at 60
°C at diﬀerent time increments by using a Bruker Avance 400
MHz spectrometer. As an external standard, 25% H3PO4 in
D2O in a sealed capillary was used.
CD Spectroscopy. To study the eﬀect of increasing % of
the surfactant on the secondary structure of HSA, solutions
containing HSA (5 μM) and increasing % w/v of CHAPS (0−
5%) in phosphate buﬀer (10 mM, pH 7.4) were prepared. To
study the eﬀect of increasing concentrations of Zr-POM on the
secondary structure of HSA in the presence of a speciﬁc %
surfactant, solutions containing HSA (5 uM) and K15H[Zr-(α2-
P2W17O61)2]·25H2O (0−25 μM) in a certain % surfactant
(0.5% CHAPS) in phosphate buﬀer (10 mM, pH 7.4) were also
prepared. CD measurements were performed at RT using a
Jasco J-1500 spectropolarimeter, and each sample was
separately measured in a quartz cell with an optical path length
of 1 mm. Scans were recorded in the far-UV wavelength region
(λ = 200−260 nm), where peptide bond absorption takes place.
For each CD measurement, a baseline correction was
performed by subtracting the spectrum of the respective buﬀer
solution with its speciﬁc % surfactant from the spectrum of the
protein.
Fluorescence Spectroscopy. Steady-state ﬂuorescence
experiments were recorded on a Photon Technology Quanta
Master QM-6/2005 spectroﬂuorimeter. Quartz cuvettes with a
10.0 mm optical path length were used. Spectra were recorded
in a buﬀered 10 μM protein concentration solution (phosphate
buﬀer, pH = 7.4) at room temperature monitoring the emission
from 305 to 400 or 420 nm, with a maximum at approximately
330 nm. Excitation of the sample took place at 295 nm to avoid
excitation of tyrosine residues. The emission and excitation slit
widths were opened at 0.37 mm (resolution of 1.0 nm). The
following concentrations of the used surfactants in the absence
of POM were measured: 0, 0.2, 0.5, 1.0, 2.0, and 5.0% w/v. The
Zr1-WD2 POM concentration was increased stepwise from 0
to 10 μM with increments of 1.0 μM and in the presence of
0.5% w/v of surfactant. The analysis of the results for the Zr1-
WD2 POM in the presence of SDS was carried out with the
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(1)
where F0 is the unquenched ﬂuorescence intensity, F the
ﬂuorescence in the presence of the quencher, and [Q] the
concentration of the quencher.
The ﬂuorescence data of the Zr1-WD2 POM in the presence
of CHAPS were analyzed using a diﬀerent equation because we
expect the number of bound molecules to be higher than 1. For
this reason, the Tachiya model,52 eq 2, is used












log log log [Q] [M]0 q
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(2)
where F0 is the unquenched ﬂuorescence intensity, F the
ﬂuorescence in the presence of the quencher, [Q] the
concentration of the quencher, [M] the concentration of the
protein, and m the number of binding sites.
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